Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-13-Speech-3-616-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Defective silicone gel breast implants made by French company PIP (debate)2
dcterms:Language	"es"^^xsd:language2
lpv:document identification number	"en.20120613.33.3-616-000"2
lpv:hasSubsequent	lp_eu:2012-06-13-Speech-3-617-0002
lpv:speaker	lp:Izaskun Bilbao Barandica2
lpv:spokenAs	member; TRAN (2012-01-19--2014-06-30)3 unknown; Partido Nacionalista Vasco (2009-07-14--2014-06-30)3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3 substitute; PECH (2012-01-19--2014-06-30)3 substitute; Delegation for relations with the Mercosur countries (2009-09-16--2014-06-30)3 substitute; FEMM (2012-01-19--2014-06-30)3 vice-chair; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Madam President, I hope that the reform of EU legislation on the control of medical devices and implants is as complete as the proposals contained in this resolution. We have learnt a lot of lessons from the PIP implant crisis, and a large number of the solutions are on the table. It is imperative that data is exchanged, warning systems are set up for EU-wide notification of any incidents, mechanical and clinical tests on the implants are improved, and transparent and improved information is available to patients. We need a penalty system that applies to suppliers that sell dangerous merchandise and to professionals along the trade and health care chain who do not collaborate with this effort towards transparency, monitoring and control. They are ethical and scientific demands along the same lines as it being fair to arbitrate compensation for the victims of this episode. There also things that are not easy to express aloud and to add here in a week in which financial voracity continues to swallow up our efforts to save the European project, which also contributes towards citizens’ well-being through issues such as the one being debated now. Let us remember that the alarming price difference between the products manufactured by PIP and those on offer from its competitors did not prompt enhanced control. The price, however, was the basis for PIP’s success in the implant market, and this had repercussions on the patients, the women. I am sure that through these controls, European medical organisations will allocate the means to prevent this from ever happening again, but it is the Commission’s responsibility to urgently implement a monitoring and control system, and Parliament’s responsibility to control the content for compliance with this resolution. For that reason, Commissioner, we hope you keep to your word."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph